+
Site Tour

Case Parade | Tricuspid focus

Three intriguing cases, each highlighting unexpected challenges encountered during tricuspid valve interventions.

Learn More:

AV Valves Summit 2024

Related Videos

AV Valves Summit 2024 | Closing of Day 1

Navigating the Anatomy | Mitral focus

Review the Trends | Mitral focus

AV Valves Summit 2024 | Closing of Day 2

Case Transmission | Tricuspid focus

PremiClose 2024: Neo-Ped Cardio Team

MitraClip - AVVS 1 year 1 minute Mitral - Video

LAAO Summit 2023: The clinical reality

LAAO Summit - TEE vs CT leaks

ESC 2023 Tutorial – TriClip™ | Prof. Donal

AV VALVES 2023: TR – Big Gaps

AV VALVES 2023: The Genesis of TEER

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Navigating the Anatomy | Mitral focus

Navigating the Anatomy | Mitral focus

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

CONNEXT


TV
RELATED RESOURCES

CardioMems™

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

Animation: Piccolo™

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

CONNEXT


HUB
RELATED RESOURCES

EXPAND Study: Data overview

Poster: Primary MR in the Very Elderly

PDA Patient Guide

bRIGHT study

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline